embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes
Embecta Corp. (EMBC)
Company Research
Source: GlobeNewswire
PARSIPPANY, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced its sponsorship of a symposium at the Advanced Technologies & Treatments for Diabetes (ATTD) international conference. This event is scheduled for Wednesday, March 6, at 10:40 a.m. Eastern Standard Time / 14:40 Central European Time. Additionally, six embecta-sponsored abstracts focusing on injection and insulin pump therapies have been selected for presentation as scientific posters at ATTD 2024. Entitled “Unlocking the potential of insulin pumps for personalized T2D care,” the symposium aims to highlight the significance of insulin pump therapy among the extensive treatment options available for type 2 diabetes (T2D). Through a series of presentations and a panel discussion led by distinguished faculty, participants will gain insight into clinical considerations for initiating insulin pump therapy
Show less
Read more
Impact Snapshot
Event Time:
EMBC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EMBC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EMBC alerts
High impacting Embecta Corp. news events
Weekly update
A roundup of the hottest topics
EMBC
News
- embecta to Report Fiscal Second Quarter 2024 Financial ResultsGlobeNewswire
- Europe Pen Needles Market Forecast Report to 2030, Featuring Embecta, Novo Nordisk, Ypsomed, B.Braun Melsungen, Terumo, Nipro, Owen Mumford, Arkray, UltiMed and Allison Medical [Yahoo! Finance]Yahoo! Finance
- Embecta (NASDAQ:EMBC) Has Affirmed Its Dividend Of $0.15 [Yahoo! Finance]Yahoo! Finance
- Embecta Corp. (NASDAQ:EMBC) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Why Embecta Stock Is Tanking Today [Yahoo! Finance]Yahoo! Finance
EMBC
Earnings
- 2/9/24 - Beat
EMBC
Sec Filings
- 4/23/24 - Form 3/A
- 4/23/24 - Form 3/A
- 4/8/24 - Form 4
- EMBC's page on the SEC website